Discussion
The U.S. Food and Drug Administration’s (FDA) recent approval of Takeda‘s injection therapy Mimrylo (rusfertide) to treat excessive blood cell production in adults with…
Polycythemia vera
What is PV? Polycythemia vera (PV) is a rare condition that causes certain blood cells to grow abnormally. While it primarily affects your red blood cells, the condition may also affect your white blood cells and platelets, the blood cell fragments that help your blood clot. Because PV causes blood…
Polycythemia vera (PV) is a rare, slow-growing blood cancer that causes your body to produce too many red blood cells. It can also increase the levels of your white blood cells and platelets, the blood cell fragments that help your blood clot. Although PV cannot be cured, treatment can…
Latest News
Discussion
Discussion
Inflammation plays a key role in the progression of polycythemia vera (PV), making it an important potential treatment target. In a new Perspective article,…
Discussion
Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for blood draws to manage the…
Polycythemia vera (PV) is a chronic, slow-growing blood cancer that causes your body to produce too many blood cells, especially red blood cells.
Polycythemia vera (PV) is a chronic, slow-growing blood cancer that causes your bone marrow to produce too many red blood cells. Some people…
Polycythemia vera (PV) is a chronic, slow-growing blood cancer that can affect your red blood cells, white blood cells, and platelets (the cell fragments…
Polycythemia vera (PV) is a slow-growing blood cancer that causes your body to produce too many blood cells, especially red blood cells. This…
Polycythemia vera (PV) is a chronic, slow-growing blood cancer marked by the production of too many blood cells, which can make you more prone to…
